Two laryngeal cancer cell lines, HEp‐2 and TU212, were infected with NKILA‐inhibiting (LV‐shNKILA‐1, LV‐shNKILA‐2, or LV‐shNKILA‐3) or overexpressing lentivirus (LV‐NKILA) to achieve NKILA knockdown or overexpression, as confirmed using real‐time PCR assays. Here, NKILA is linked to laryngeal carcinoma.